cholestyramine light

Generic: cholestyramine

Labeler: tagi pharma, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name cholestyramine light
Generic Name cholestyramine
Labeler tagi pharma, inc.
Dosage Form POWDER, FOR SUSPENSION
Routes
ORAL
Active Ingredients

cholestyramine 4 g/4.8g

Manufacturer
TAGI Pharma, Inc.

Identifiers & Regulatory

Product NDC 51224-009
Product ID 51224-009_fb8b0e9c-1750-4016-95c7-d7a49e09d463
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA209599
Marketing Start 2020-11-12
Marketing End 2027-01-31

Pharmacologic Class

Established (EPC)
bile acid sequestrant [epc]
Mechanism of Action
bile-acid binding activity [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 51224009
Hyphenated Format 51224-009

Supplemental Identifiers

RxCUI
1801279
UNII
4B33BGI082
NUI
N0000180292 N0000175365

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cholestyramine light (source: ndc)
Generic Name cholestyramine (source: ndc)
Application Number ANDA209599 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 4 g/4.8g
source: ndc
Packaging
  • 201.6 g in 1 CAN (51224-009-10)
source: ndc

Packages (1)

51224-009-10 201.6 g in 1 CAN (51224-009-10)

Ingredients (1)

cholestyramine (4 g/4.8g)

Linked Drug Pages (1)

Cholestyramine Light ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "fb8b0e9c-1750-4016-95c7-d7a49e09d463", "openfda": {"nui": ["N0000180292", "N0000175365"], "unii": ["4B33BGI082"], "rxcui": ["1801279"], "spl_set_id": ["eb85a2c8-cdc3-48bb-844d-e220ae3701a0"], "pharm_class_epc": ["Bile Acid Sequestrant [EPC]"], "pharm_class_moa": ["Bile-acid Binding Activity [MoA]"], "manufacturer_name": ["TAGI Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "201.6 g in 1 CAN (51224-009-10)", "package_ndc": "51224-009-10", "marketing_end_date": "20270131", "marketing_start_date": "20201112"}], "brand_name": "Cholestyramine Light", "product_id": "51224-009_fb8b0e9c-1750-4016-95c7-d7a49e09d463", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Bile Acid Sequestrant [EPC]", "Bile-acid Binding Activity [MoA]"], "product_ndc": "51224-009", "generic_name": "Cholestyramine", "labeler_name": "TAGI Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cholestyramine Light", "active_ingredients": [{"name": "CHOLESTYRAMINE", "strength": "4 g/4.8g"}], "application_number": "ANDA209599", "marketing_category": "ANDA", "marketing_end_date": "20270131", "marketing_start_date": "20201112"}